Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

Continue Reading Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases
An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation

According to a story from BioSpace, the radiopharmaceutical company Clarity Pharmaceuticals, Inc. has announced recently that its experimental diagnostic 64Cu-SARTATE™ has earned Rare Pediatric Disease designation from the US Food…

Continue Reading An Experimental Diagnostic for Neuroblastoma has Earned Rare Pediatric Disease Designation
New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study
source: pixabay.com

New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Ionis Pharmaceuticals has just released their findings from a study investigating the effect of IONIS-PKK-LRx and IONIS-PKKRx in hereditary angioedema (HAE) patients with different forms of the disease. These therapies work to reduce…

Continue Reading New Investigative Therapy for Hereditary Angioedema Found Efficacious in Study

Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate

A new study published in the journal Rheumatology and Therapy examined the effect of baricitinib on Rheumatoid Arthritis (RA) patients who have had an inadequate to their methotrexate therapy. Methotrexate and Baricitinib…

Continue Reading Study Finds New Therapy to be Efficacious for Rheumatoid Arthritis Patients Unresponsive to Methotrexate
Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
source: pixabay.com

Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers

Researchers in Canada have just released positive results from their heterozygous familial hypercholesterolemia (HeFH) clinical trial. This investigation was examining the effect of Repatha on teenagers with the condition. The trial…

Continue Reading Heterozygous Familial Hypercholesterolemia Trial Shows Positive Results of Therapy in Teenagers
ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
source: pixabay.com

ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder

Health Canada has recently granted market authorization to Hoffman La-Roche Limited for their neuromyelitis optica spectrum disorder treatment, ENSPRYNG. Canada is the first country to offer this medication, and hopefully…

Continue Reading ENSPRYNG Now Available to Canadians with Neuromyelitis Optica Spectrum Disorder
Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
https://pixabay.com/photos/swing-playground-children-playing-1188132/

Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida

Dayton Abbott is like many kindergarteners; she loves to tell jokes, play games, and hang out with friends during recess. But her playground at Alexander Elementary School wasn't built for…

Continue Reading Mom Raises $10k to Create Inclusive Playground for Daughter with Spina Bifida
CUTX-101 Shows Promise for Menkes Disease
https://pixabay.com/en/copper-scrap-metal-scrap-disposal-1504098/

CUTX-101 Shows Promise for Menkes Disease

Recently, biopharmaceutical company Fortress Biotech announced positive clinical results for CUTX-101 (copper histidinate). The data highlights the efficacy of CUTX-101 for patients with Menkes disease. As there are currently no…

Continue Reading CUTX-101 Shows Promise for Menkes Disease